Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-discovery projects, its application to G protein-coupled receptors (GPCRs) has been limited owing to extreme difficulties with their crystallization. Here, a method is presented for the rapid determination of multiple co-crystal structures for a target GPCR in complex with various ligands, taking advantage of the serial femtosecond crystallography approach, which obviates the need for large crystals and requires only submilligram quantities of purified protein. The method was applied to the human β(2)-adrenergic receptor, resulting in eight room-temperature co-crystal structures with six different ligands, including previously unreported structures with carvedilol and propranolol. The generality of the proposed method was tested with three other receptors. This approach has the potential to enable SBDD for GPCRs and other difficult-to-crystallize membrane proteins.
Toward G protein-coupled receptor structure-based drug design using X-ray lasers.
利用X射线激光进行基于G蛋白偶联受体结构的药物设计
阅读:4
作者:Ishchenko Andrii, Stauch Benjamin, Han Gye Won, Batyuk Alexander, Shiriaeva Anna, Li Chufeng, Zatsepin Nadia, Weierstall Uwe, Liu Wei, Nango Eriko, Nakane Takanori, Tanaka Rie, Tono Kensuke, Joti Yasumasa, Iwata So, Moraes Isabel, Gati Cornelius, Cherezov Vadim
| 期刊: | IUCrJ | 影响因子: | 3.600 |
| 时间: | 2019 | 起止号: | 2019 Oct 24; 6(Pt 6):1106-1119 |
| doi: | 10.1107/S2052252519013137 | 研究方向: | 免疫/内分泌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
